🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMetabolic Health & DiabetesSURPASS-CVOT: tirzepatide cardiovascular outcomes trial design — anyone have experience? Page 4

SURPASS-CVOT: tirzepatide cardiovascular outcomes trial design — anyone have experience?

MeganSA_TX Tue, Jan 9, 2024 at 10:31 AM 18 replies 2,325 viewsPage 4 of 4
sarah_TO
Member
278
1,234
Sep 2024
Toronto, CA
Jan 17, 2024 at 4:59 AM#16

Adding the clinical framing, because it changes how the question reads. Take it one variable at a time. Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent argument can untangle them after the fact.

Ask again with the specifics and you will get a better answer than this one.

25 0andrew_nyc, Dr.EndoEP, GraceAZ_72 and 22 others
Reply Quote Save Share Report
jason_sac26
New Member
34
123
Jan 2026
Sacramento, CA
Jan 18, 2024 at 11:20 AM#17
sarah_TO said:
Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent…

Same pattern here, and in the same order.

24 24Dr.EM_Chicago, pete_RVA, CarlaRPh_TPA and 21 others
Reply Quote Save Share Report
andrew_nyc
Member
534
2,345
Apr 2024
New York, NY
Jan 19, 2024 at 5:41 PM#18
sarah_TO said:
Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent…

Adding the part of the answer the thread has not reached. Worth answering the question that was asked rather than the one behind it. The narrow version usually has an answer; the broad version usually does not, and answering the broad one is how a thread stops being useful.

23 23PharmD_Rodriguez, julia.endo, JessicaM_2024 and 20 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
kate.chem
VIP Member
3,890
17,654
Dec 2023
California
Jan 21, 2024 at 12:03 AM#19

The figures, for anyone assembling their own picture. If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way. Most of the apparent contradictions in these threads dissolve at that step.

22 22jennifer_SEA, tyler_CSCS, VanRx_Mike and 19 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Jan 22, 2024 at 6:26 AM#20

Moderator note: a couple of off-topic posts removed. Thread quality here is what the rules are for. Keep it up.

50 0PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 47 others
Reply Quote Save Share Report

Similar Threads

SUSTAIN-6 to SELECT — the cardiovascular evidence timeline14 replies
GLP-1 and insulin resistance — HOMA-IR improvement data17 replies
Metabolic syndrome reversal criteria — how GLP-1 addresses all 55 replies
A1C target achievement rates — sema vs tirz comparison8 replies
SURPASS-CVOT: tirzepatide cardiovascular outcomes trial design3 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register